APA (7th ed.) Citation

LP, G., B, B., & SD, N. (2025). Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD. Clinical journal of the American Society of Nephrology : CJASN. https://doi.org/10.2215/CJN.0000000973

Chicago Style (17th ed.) Citation

LP, Gregg, Bozkurt B, and Navaneethan SD. "Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD." Clinical Journal of the American Society of Nephrology : CJASN 2025. https://doi.org/10.2215/CJN.0000000973.

MLA (9th ed.) Citation

LP, Gregg, et al. "Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD." Clinical Journal of the American Society of Nephrology : CJASN, 2025, https://doi.org/10.2215/CJN.0000000973.